Home
Contact Us

Event Profile

340B Drug Pricing Program: Past, Present and Future

Date(s):
September 26, 2018
Description:
Credit: 0 Credit Hours
 
**Pre-registration is now closed for this program. On-site registration is still available. Please arrive 10 minutes before the program to register with event staff.
 
As the drug pricing debate takes center stage on the Hill, the federal 340B drug pricing program faces an uncertain future. Hear from an expert panel that will provide an overview of the 340B program, an update on legislative and regulatory developments, and an outlook on the future of the program.
 
Pre-registration for this program is encouraged. As always, please feel free to share this invitation with colleagues. D.C. Bar membership is not required to attend. Food is available on a first-come, first-served basis. Doors open at 11:30 am.
 
Are you a law student and looking to register for one of our programs? Join the new Law Student Community and attend most individual programs at a discounted rate. Find out more here.
 
Sponsored by: D.C. Bar Health Law Community
 
**This program is available for both in-person attendance and live webcast participation. To access webcast registration, please click here.
 
Please Note: Requests for changes to registration from in-person attendance to webcast must be made by 10:00 am the day of the event.
 
Speakers:
  • Alan Arville, Member, Epstein Becker & Green P.C.
  • Jeffrey I. Davis, Counsel/Senior Advisor, Baker Donelson
  • Amanda Nagrotsky, Legal Counsel, 340B Health
  • Shuchi Parikh, Associate, Powers Pyles Sutter & Verville PC
  • Jason Reddish, Partner, Feldesman Tucker Leifer Fidell LLP
  • Lee Rosebush, Partner, BakerHostetler
 
In-Person Fees: $0 Sponsoring Community Member; $10 Law Student Community; $15 Government/NonProfit; $20 D.C. Bar Member; $25 Non-Member
 
Please select Individual Registration to register.
Share:

Find it on Map

D.C. Bar
Amanda Nagrotsky, Legal Counsel, 340B Health

Lee Rosebush, Partner, BakerHostetler

Alan Arville, Member, Epstein Becker & Green P.C.

Jason Reddish, Partner, Feldesman Tucker Leifer Fidell LLP

Jeffrey Davis, Counsel/Senior Advisor, Baker Donelson

Shuchi Parikh, Associate, Powers Pyles Sutter & Verville PC

Alternate Text